Article
Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
18 Jun 2014
Abstract excerpt
BACKGROUND: Glioma is the most common primary malignant central nervous system tumor in adult, and is usually not curable due to its invasive nature. Establishment of serum biomarkers for glioma would be beneficial both for early diagnosis and adequate therapeutic intervention. Filamins are an actin cross-linker and filamin C (FLNC), normally restricted in muscle tissues, offers many signaling molecules an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
